PHARMARON (03759) announced that the company recently received a notification letter from Xinzhong Kangcheng and its acting-in-concert party Shenzhen Xinzhong Longcheng Investment Partnership (Limited Partnership) (hereinafter referred to as "Xinzhong Longcheng"). The notification disclosed that Xinzhong Kangcheng's current share reduction plan has been fully implemented, with a cumulative disposal of 26.6729 million shares.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.